David Rinaldi
Impact in
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Neutropenia and Cancer Infections
-
- Lung Cancer Treatments and Mutations
- Gastric Cancer Management and Outcomes
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 31
- Colorectal Cancer Treatments and Studies 13
- Cancer Treatment and Pharmacology 12
- Lung Cancer Research Studies 12
- Neutropenia and Cancer Infections 5
-
- Lung Cancer Treatments and Mutations 14
- Lung Cancer Diagnosis and Treatment 4
- Co-authors
- Howard A. BurrisDaniel D. Von HoffJohn R. EckardtJohn G. KuhnMichael C. PerryChandra P. BelaniGeoffrey R. WeissGladys Rodriguez
- Journals
- Journal of Clinical Oncology (11 papers)Cancer (4 papers)Anti-Cancer Drugs (3 papers)Annals of Oncology (3 papers)Lung Cancer (3 papers)
- Partner nations
- United StatesFranceCanada
In The Last Decade
David Rinaldi
38 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 86
- Oncology 1.3k
- Pulmonary and Respiratory Medicine 867
- Hepatology 151
- Genetics 174
- Hematology 106
Countries citing papers authored by David Rinaldi
This map shows the geographic impact of David Rinaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Rinaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Rinaldi more than expected).
Fields of papers citing papers by David Rinaldi
This network shows the impact of papers produced by David Rinaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Rinaldi. The network helps show where David Rinaldi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Rinaldi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 1 | |
| 2 | 2006 | 6 | |
| 3 | 2006 | 15 | |
| 4 | 2005 | 43 | |
| 5 | Randomized double-blind phase 2 study evaluating sameday vs next-day administration of pegfilgrastim with docetaxel, doxorubicin, and cyclophosphamide (tac) in women with early stage and advanced breast cancer | 2004 | 12 |
| 6 | 2004 | 22 | |
| 7 | 2003 | 92 | |
| 8 | 2003 | 1 | |
| 9 | 2003 | 20 | |
| 10 | 2002 | 3 | |
| 11 | 2001 | 32 | |
| 12 | 2001 | 9 | |
| 13 | 2001 | 7 | |
| 14 | 2000 | 5 | |
| 15 | 1999 | 158 | |
| 16 | 1996 | 3 | |
| 17 | 1996 | 34 | |
| 18 | 1996 | 305 | |
| 19 | 1995 | 132 | |
| 20 | 1993 | 18 |
About David Rinaldi
David Rinaldi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Dermatology and Cancer Research, having authored 38 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), Colorectal Cancer Treatments and Studies (13 papers), Cancer Treatment and Pharmacology (12 papers), Lung Cancer Research Studies (12 papers), Cancer therapeutics and mechanisms (6 papers), Neutropenia and Cancer Infections (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (867 citations), Hepatology (151 citations), Genetics (174 citations) and Hematology (106 citations). David Rinaldi has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Howard A. Burris, Daniel D. Von Hoff, John R. Eckardt, John G. Kuhn, Michael C. Perry, Chandra P. Belani, Geoffrey R. Weiss, Gladys Rodriguez, Charles S. Fuchs and S. Gail Eckhardt. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Anti-Cancer Drugs, Annals of Oncology and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.